White paper: Adopting novel technologies to improve mAb processes
Feb. 20, 2024
Are purification strategies for mAbs moving you forward, or holding you back?
As demand for structurally diverse mAbs grows, the purification process becomes more challenging. Study results show the efficacy of new technologies that address these hurdles, so customers are better prepared to meet growing demand and patient need:
Detergent-based viral inactivation that is biodegradable and maintains the integrity of the protein of interest
Enhanced chromatography ligand with higher dynamic binding capacity
Additives in wash step successfully reduces aggregation
Novel excipients reduce protein-protein interactions and improves stability
